Diabetes
56:1174-1176,
2007
DOI: 10.2337/db06-1555
© 2007 by the American Diabetes Association
Toward Further Mapping of the Association Between the IL2RA Locus and Type 1 Diabetes
Hui-Qi Qu1,
Alexander Montpetit2,
Bing Ge2,
Thomas J. Hudson2, and
Constantin Polychronakos1
1 Endocrine Genetics Laboratory, McGill University Health Center (Montréal Children's Hospital), Montréal, Québec, Canada
2 McGill University and Genome Québec Innovation Centre, Montréal, Québec, Canada
Address correspondence and reprint requests to Dr. Constantin Polychronakos McGill University Health Center (Montréal Children's Hospital), 2300 Tupper, Montréal, Qc H3H 1P3, Canada. E-mail: constantin.polychronakos{at}mcgill.ca
Abbreviations:
IL, interleukin; LD, linkage disequilibrium; SNP, single nucleotide polymorphism
A novel type 1 diabetes locus was mapped to the interleukin-2 receptor gene (IL2RA) on chromosome 10p15.1, encoding an important modulator of immunity. The aim of the current study was to confirm the association of IL2RA with type 1 diabetes and to attempt further mapping of the genetic effect with a new set of 12 single nucleotide polymorphisms (SNPs). We genotyped 949 nuclear family trios with one type 1 diabetes–affected offspring and two parents (2,847 individuals). Two of the 12 IL2RA SNPs genotyped (rs706778 and rs3118470) had statistically significant type 1 diabetes association (P = 6.96 x 10–4 and 8.63 x 10–4, respectively). Both SNPs are located in the 5' end of the long intron 1 within 3 kb of each other and are in high linkage disequilibrium (D' = 0.997, r2 = 0.613). The A-C haplotype (frequency = 0.331) was associated with increased type 1 diabetes risk (P = 3.02 x 10–4). Our study identifies two markers in the IL2RA gene that are significantly associated with type 1 diabetes, supporting IL2RA as a promising candidate gene for type 1 diabetes and suggesting a potential role of IL2R in the pathogenesis of type 1 diabetes, likely involving regulatory T-cells.

CiteULike Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
D.-A. Tregouet, P.-H. Groop, S. McGinn, C. Forsblom, S. Hadjadj, M. Marre, H.-H. Parving, L. Tarnow, R. Telgmann, T. Godefroy, et al.
G/T Substitution in Intron 1 of the UNC13B Gene Is Associated With Increased Risk of Nephropathy in Patients With Type 1 Diabetes
Diabetes,
October 1, 2008;
57(10):
2843 - 2850.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
V. Butty, C. Campbell, D. Mathis, C. Benoist, and the DPT-1 Study Group
Impact of Diabetes Susceptibility Loci on Progression From Pre-Diabetes to Diabetes in At-Risk Individuals of the Diabetes Prevention Trial-Type 1 (DPT-1)
Diabetes,
September 1, 2008;
57(9):
2348 - 2359.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. J. Smyth, J. D. Cooper, J. M.M. Howson, N. M. Walker, V. Plagnol, H. Stevens, D. G. Clayton, and J. A. Todd
PTPN22 Trp620 Explains the Association of Chromosome 1p13 With Type 1 Diabetes and Shows a Statistical Interaction With HLA Class II Genotypes
Diabetes,
June 1, 2008;
57(6):
1730 - 1737.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Hakonarson, H.-Q. Qu, J. P. Bradfield, L. Marchand, C. E. Kim, J. T. Glessner, R. Grabs, T. Casalunovo, S. P. Taback, E. C. Frackelton, et al.
A Novel Susceptibility Locus for Type 1 Diabetes on Chr12q13 Identified by a Genome-Wide Association Study
Diabetes,
April 1, 2008;
57(4):
1143 - 1146.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2007 by the American Diabetes Association.
|
|
| |
|